Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
DNA Methylation | 33 | 2023 | 4384 | 1.900 |
Why?
|
Sequence Analysis, DNA | 9 | 2020 | 4739 | 1.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 11 | 2014 | 3777 | 1.000 |
Why?
|
Epigenesis, Genetic | 24 | 2023 | 3788 | 0.950 |
Why?
|
Software | 7 | 2019 | 4431 | 0.840 |
Why?
|
Chromatin | 15 | 2024 | 2946 | 0.830 |
Why?
|
High-Throughput Nucleotide Sequencing | 11 | 2021 | 3634 | 0.800 |
Why?
|
Single-Cell Analysis | 11 | 2024 | 2451 | 0.680 |
Why?
|
Epigenomics | 12 | 2022 | 944 | 0.670 |
Why?
|
Placentation | 1 | 2017 | 78 | 0.570 |
Why?
|
Genome | 9 | 2019 | 1738 | 0.550 |
Why?
|
Quality Control | 1 | 2019 | 833 | 0.520 |
Why?
|
CpG Islands | 8 | 2021 | 1190 | 0.520 |
Why?
|
Programming Languages | 1 | 2016 | 130 | 0.510 |
Why?
|
Molecular Sequence Annotation | 1 | 2018 | 518 | 0.500 |
Why?
|
Endonucleases | 5 | 2019 | 370 | 0.490 |
Why?
|
Algorithms | 11 | 2019 | 14025 | 0.450 |
Why?
|
DNA | 7 | 2023 | 7189 | 0.430 |
Why?
|
Cell Lineage | 10 | 2024 | 2548 | 0.400 |
Why?
|
Sulfites | 3 | 2021 | 82 | 0.390 |
Why?
|
Meta-Analysis as Topic | 1 | 2016 | 1381 | 0.360 |
Why?
|
Gene Expression Profiling | 11 | 2024 | 9416 | 0.360 |
Why?
|
Computational Biology | 5 | 2020 | 3499 | 0.340 |
Why?
|
Gene Expression Regulation, Neoplastic | 13 | 2024 | 8530 | 0.330 |
Why?
|
Genetic Heterogeneity | 1 | 2013 | 734 | 0.320 |
Why?
|
Genome, Human | 10 | 2021 | 4423 | 0.320 |
Why?
|
Placenta | 1 | 2017 | 1711 | 0.310 |
Why?
|
Substrate Specificity | 4 | 2019 | 1768 | 0.280 |
Why?
|
Diarrhea | 4 | 2016 | 1316 | 0.270 |
Why?
|
High-Throughput Screening Assays | 2 | 2019 | 931 | 0.270 |
Why?
|
Carcinoma | 1 | 2017 | 2330 | 0.260 |
Why?
|
GATA1 Transcription Factor | 3 | 2022 | 296 | 0.260 |
Why?
|
Models, Statistical | 2 | 2019 | 5081 | 0.250 |
Why?
|
Gene Targeting | 4 | 2021 | 838 | 0.240 |
Why?
|
RNA-Binding Protein EWS | 4 | 2023 | 210 | 0.240 |
Why?
|
Thrombocytosis | 1 | 2024 | 88 | 0.230 |
Why?
|
DNA, Mitochondrial | 2 | 2020 | 865 | 0.230 |
Why?
|
Thrombocythemia, Essential | 1 | 2024 | 113 | 0.220 |
Why?
|
Bone Neoplasms | 3 | 2022 | 2527 | 0.210 |
Why?
|
Hematopoietic Stem Cells | 6 | 2019 | 3388 | 0.210 |
Why?
|
Chromatin Assembly and Disassembly | 2 | 2019 | 634 | 0.200 |
Why?
|
Heterochromatin | 2 | 2022 | 291 | 0.200 |
Why?
|
Metabolomics | 3 | 2021 | 1658 | 0.200 |
Why?
|
Embryonic Stem Cells | 4 | 2014 | 1246 | 0.200 |
Why?
|
Sarcoma, Clear Cell | 1 | 2022 | 72 | 0.190 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 2022 | 224 | 0.190 |
Why?
|
Genomics | 6 | 2019 | 5828 | 0.190 |
Why?
|
Prostatic Neoplasms | 5 | 2023 | 11101 | 0.190 |
Why?
|
Sequence Analysis, RNA | 5 | 2019 | 2011 | 0.180 |
Why?
|
Diploidy | 1 | 2020 | 133 | 0.180 |
Why?
|
Chromosomes | 2 | 2020 | 578 | 0.180 |
Why?
|
Humans | 81 | 2024 | 761208 | 0.180 |
Why?
|
Alleles | 3 | 2024 | 6857 | 0.180 |
Why?
|
Cell Differentiation | 9 | 2024 | 11509 | 0.180 |
Why?
|
RNA Editing | 2 | 2019 | 149 | 0.170 |
Why?
|
Cytosine Deaminase | 1 | 2020 | 66 | 0.170 |
Why?
|
Liver Diseases | 2 | 2019 | 1301 | 0.170 |
Why?
|
Hematopoiesis | 4 | 2020 | 2046 | 0.170 |
Why?
|
DNA Breaks | 1 | 2019 | 47 | 0.170 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2022 | 1726 | 0.170 |
Why?
|
Deoxyribonucleases | 2 | 2019 | 209 | 0.170 |
Why?
|
Chromatin Immunoprecipitation | 2 | 2022 | 848 | 0.160 |
Why?
|
Interleukins | 1 | 2024 | 782 | 0.160 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2024 | 2293 | 0.160 |
Why?
|
Erythropoiesis | 2 | 2022 | 683 | 0.160 |
Why?
|
Gene Regulatory Networks | 2 | 2021 | 1743 | 0.160 |
Why?
|
Deoxyribonucleases, Type II Site-Specific | 2 | 2021 | 166 | 0.160 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 2 | 2021 | 104 | 0.160 |
Why?
|
Bacterial Proteins | 3 | 2019 | 3836 | 0.160 |
Why?
|
Th1 Cells | 1 | 2024 | 1042 | 0.160 |
Why?
|
RNA | 5 | 2022 | 2709 | 0.160 |
Why?
|
Linkage Disequilibrium | 3 | 2019 | 1994 | 0.160 |
Why?
|
DNA, Circular | 1 | 2018 | 96 | 0.150 |
Why?
|
Proteome | 1 | 2008 | 1856 | 0.150 |
Why?
|
Genome, Plant | 1 | 2018 | 82 | 0.150 |
Why?
|
Oncogene Proteins, Fusion | 4 | 2023 | 1605 | 0.150 |
Why?
|
Chimerism | 1 | 2019 | 155 | 0.150 |
Why?
|
HEK293 Cells | 7 | 2020 | 4243 | 0.150 |
Why?
|
Databases, Nucleic Acid | 1 | 2019 | 205 | 0.150 |
Why?
|
Zea mays | 1 | 2018 | 110 | 0.150 |
Why?
|
Histones | 4 | 2022 | 2570 | 0.150 |
Why?
|
Colonic Neoplasms | 3 | 2017 | 2527 | 0.150 |
Why?
|
Cell Cycle Proteins | 2 | 2021 | 3446 | 0.150 |
Why?
|
Mitosis | 1 | 2022 | 1186 | 0.140 |
Why?
|
Hematopoiesis, Extramedullary | 1 | 2017 | 53 | 0.140 |
Why?
|
Virus Integration | 1 | 2019 | 304 | 0.140 |
Why?
|
Chromosome Mapping | 4 | 2019 | 4612 | 0.140 |
Why?
|
Polymorphism, Single Nucleotide | 8 | 2021 | 15920 | 0.140 |
Why?
|
Otx Transcription Factors | 1 | 2017 | 42 | 0.140 |
Why?
|
Streptococcus pyogenes | 2 | 2019 | 292 | 0.140 |
Why?
|
Cerebellum | 1 | 2024 | 1501 | 0.140 |
Why?
|
Euchromatin | 1 | 2016 | 54 | 0.140 |
Why?
|
Colorectal Neoplasms | 5 | 2022 | 6919 | 0.130 |
Why?
|
Enhancer Elements, Genetic | 5 | 2024 | 1360 | 0.130 |
Why?
|
Promoter Regions, Genetic | 4 | 2021 | 5773 | 0.130 |
Why?
|
Ribonucleoproteins | 1 | 2019 | 356 | 0.130 |
Why?
|
Mitochondria | 2 | 2020 | 3620 | 0.130 |
Why?
|
K562 Cells | 1 | 2018 | 640 | 0.130 |
Why?
|
Osteosarcoma | 1 | 2022 | 896 | 0.130 |
Why?
|
Liver Neoplasms | 2 | 2024 | 4309 | 0.130 |
Why?
|
Lung Neoplasms | 4 | 2024 | 13385 | 0.130 |
Why?
|
Interferon-gamma | 1 | 2024 | 3155 | 0.130 |
Why?
|
Schizosaccharomyces pombe Proteins | 1 | 2016 | 178 | 0.130 |
Why?
|
Databases, Genetic | 2 | 2014 | 1741 | 0.120 |
Why?
|
Azacitidine | 1 | 2017 | 336 | 0.120 |
Why?
|
Twins, Monozygotic | 1 | 2016 | 470 | 0.120 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2017 | 781 | 0.120 |
Why?
|
Pregnancy Trimester, Second | 1 | 2017 | 732 | 0.120 |
Why?
|
Induced Pluripotent Stem Cells | 3 | 2011 | 1852 | 0.120 |
Why?
|
Schizosaccharomyces | 1 | 2016 | 237 | 0.120 |
Why?
|
Dependovirus | 1 | 2019 | 712 | 0.120 |
Why?
|
Clone Cells | 2 | 2020 | 1668 | 0.120 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2021 | 3770 | 0.110 |
Why?
|
Epithelial Cells | 5 | 2019 | 3671 | 0.110 |
Why?
|
Bayes Theorem | 3 | 2013 | 2329 | 0.110 |
Why?
|
Workflow | 1 | 2019 | 850 | 0.110 |
Why?
|
Gene Expression Regulation, Fungal | 1 | 2016 | 493 | 0.110 |
Why?
|
Methyltransferases | 1 | 2016 | 364 | 0.110 |
Why?
|
Microfluidics | 1 | 2019 | 651 | 0.110 |
Why?
|
Jumonji Domain-Containing Histone Demethylases | 1 | 2015 | 167 | 0.110 |
Why?
|
Cell Line, Tumor | 10 | 2023 | 16952 | 0.110 |
Why?
|
Polymerase Chain Reaction | 2 | 2021 | 6067 | 0.110 |
Why?
|
Quantitative Trait Loci | 2 | 2019 | 2113 | 0.110 |
Why?
|
Pregnancy Trimester, First | 1 | 2017 | 908 | 0.110 |
Why?
|
Polymers | 1 | 2020 | 1617 | 0.110 |
Why?
|
Soft Tissue Neoplasms | 1 | 2022 | 1158 | 0.110 |
Why?
|
Pancreatic Neoplasms | 2 | 2022 | 5366 | 0.110 |
Why?
|
Animals | 23 | 2024 | 168079 | 0.110 |
Why?
|
Access to Information | 1 | 2016 | 316 | 0.110 |
Why?
|
Hemorrhage | 1 | 2024 | 3422 | 0.100 |
Why?
|
Cells | 1 | 2014 | 164 | 0.100 |
Why?
|
Transcription Factors | 4 | 2021 | 12099 | 0.100 |
Why?
|
Anemia | 1 | 2022 | 1504 | 0.100 |
Why?
|
Mice | 14 | 2024 | 81326 | 0.100 |
Why?
|
Zebrafish | 3 | 2021 | 3000 | 0.100 |
Why?
|
Genome-Wide Association Study | 7 | 2019 | 12676 | 0.100 |
Why?
|
NFI Transcription Factors | 1 | 2012 | 42 | 0.100 |
Why?
|
Haplotypes | 1 | 2018 | 2715 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2016 | 566 | 0.100 |
Why?
|
Cerebellar Neoplasms | 1 | 2017 | 586 | 0.100 |
Why?
|
Binding Sites | 4 | 2024 | 5988 | 0.100 |
Why?
|
Endothelial Cells | 1 | 2024 | 3551 | 0.100 |
Why?
|
Methionine Sulfoxide Reductases | 1 | 2012 | 77 | 0.100 |
Why?
|
Medulloblastoma | 1 | 2017 | 677 | 0.100 |
Why?
|
Protein Engineering | 1 | 2015 | 546 | 0.100 |
Why?
|
Insect Vectors | 1 | 2012 | 136 | 0.090 |
Why?
|
Gene Expression Regulation | 5 | 2024 | 11856 | 0.090 |
Why?
|
Graft vs Host Disease | 1 | 2023 | 3025 | 0.090 |
Why?
|
DNA, Intergenic | 1 | 2011 | 105 | 0.090 |
Why?
|
Neoplasms | 6 | 2022 | 22140 | 0.090 |
Why?
|
Cell Nucleolus | 1 | 2011 | 153 | 0.090 |
Why?
|
Evolution, Molecular | 1 | 2019 | 1882 | 0.090 |
Why?
|
DNA Restriction Enzymes | 1 | 2010 | 548 | 0.090 |
Why?
|
Malaria Vaccines | 1 | 2012 | 163 | 0.090 |
Why?
|
Tumor Microenvironment | 2 | 2024 | 3873 | 0.090 |
Why?
|
Lysine | 1 | 2015 | 982 | 0.090 |
Why?
|
Protein Binding | 5 | 2016 | 9297 | 0.090 |
Why?
|
Mice, Inbred NOD | 3 | 2021 | 1822 | 0.090 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2014 | 613 | 0.090 |
Why?
|
Major Histocompatibility Complex | 1 | 2013 | 872 | 0.090 |
Why?
|
Plasmodium vivax | 1 | 2012 | 202 | 0.090 |
Why?
|
Genetic Vectors | 1 | 2019 | 3388 | 0.080 |
Why?
|
Mutation | 9 | 2020 | 30002 | 0.080 |
Why?
|
Gene Rearrangement | 2 | 2016 | 1125 | 0.080 |
Why?
|
Arthritis, Rheumatoid | 2 | 2016 | 3753 | 0.080 |
Why?
|
Developing Countries | 2 | 2012 | 2863 | 0.080 |
Why?
|
Chromosomes, Human | 1 | 2011 | 442 | 0.080 |
Why?
|
Base Sequence | 5 | 2019 | 12404 | 0.080 |
Why?
|
Cell Line | 6 | 2021 | 15545 | 0.080 |
Why?
|
Protein Structure, Tertiary | 2 | 2013 | 3778 | 0.080 |
Why?
|
Cytosine | 2 | 2020 | 212 | 0.080 |
Why?
|
DNA-Binding Proteins | 4 | 2019 | 9566 | 0.080 |
Why?
|
Reproducibility of Results | 4 | 2021 | 20119 | 0.080 |
Why?
|
Osteoblasts | 3 | 2021 | 1144 | 0.080 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2012 | 570 | 0.070 |
Why?
|
Conserved Sequence | 1 | 2011 | 1162 | 0.070 |
Why?
|
Autoantibodies | 1 | 2016 | 2119 | 0.070 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2019 | 1640 | 0.070 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2023 | 5666 | 0.070 |
Why?
|
Keratinocytes | 1 | 2011 | 790 | 0.070 |
Why?
|
RNA, Small Interfering | 1 | 2016 | 3412 | 0.070 |
Why?
|
Protein Biosynthesis | 1 | 2015 | 2091 | 0.070 |
Why?
|
Two-Hybrid System Techniques | 1 | 2008 | 459 | 0.070 |
Why?
|
Early Detection of Cancer | 1 | 2021 | 3198 | 0.070 |
Why?
|
Brain Chemistry | 1 | 2010 | 959 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2024 | 4574 | 0.070 |
Why?
|
Brain | 6 | 2019 | 27092 | 0.070 |
Why?
|
Prostate | 2 | 2011 | 1772 | 0.070 |
Why?
|
Oncogenes | 3 | 2022 | 1220 | 0.060 |
Why?
|
Mesenchymal Stem Cells | 2 | 2017 | 1645 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2011 | 987 | 0.060 |
Why?
|
Recombinant Fusion Proteins | 1 | 2014 | 3726 | 0.060 |
Why?
|
DNA, Neoplasm | 1 | 2010 | 1743 | 0.060 |
Why?
|
Fetal Blood | 1 | 2011 | 1348 | 0.060 |
Why?
|
Regulatory Sequences, Nucleic Acid | 2 | 2019 | 790 | 0.060 |
Why?
|
Female | 21 | 2024 | 392544 | 0.060 |
Why?
|
Incidence | 3 | 2024 | 21365 | 0.060 |
Why?
|
Depressive Disorder, Major | 2 | 2013 | 4767 | 0.060 |
Why?
|
Data Interpretation, Statistical | 1 | 2014 | 2691 | 0.060 |
Why?
|
Lymphocytes | 3 | 2019 | 2603 | 0.060 |
Why?
|
Behavior, Animal | 1 | 2012 | 1873 | 0.060 |
Why?
|
Spleen | 1 | 2010 | 2290 | 0.060 |
Why?
|
Gene Silencing | 1 | 2010 | 1495 | 0.060 |
Why?
|
Neoplastic Cells, Circulating | 2 | 2023 | 943 | 0.060 |
Why?
|
Infant, Newborn | 5 | 2016 | 26199 | 0.060 |
Why?
|
Male | 20 | 2024 | 360693 | 0.060 |
Why?
|
Internet | 1 | 2016 | 3096 | 0.060 |
Why?
|
Toxoplasmosis | 1 | 2024 | 94 | 0.060 |
Why?
|
Antibodies | 1 | 2012 | 2415 | 0.060 |
Why?
|
Aging | 1 | 2022 | 8702 | 0.060 |
Why?
|
Sensitivity and Specificity | 2 | 2017 | 14675 | 0.050 |
Why?
|
Aged | 12 | 2024 | 169288 | 0.050 |
Why?
|
Toxoplasma | 1 | 2024 | 158 | 0.050 |
Why?
|
Gestational Age | 1 | 2012 | 3580 | 0.050 |
Why?
|
DNA Primers | 2 | 2021 | 2814 | 0.050 |
Why?
|
Cell Nucleus | 2 | 2022 | 2881 | 0.050 |
Why?
|
Colon | 1 | 2010 | 1791 | 0.050 |
Why?
|
Nerve Tissue Proteins | 2 | 2012 | 4404 | 0.050 |
Why?
|
Cost of Illness | 1 | 2012 | 1936 | 0.050 |
Why?
|
Infant | 5 | 2016 | 36169 | 0.050 |
Why?
|
Neoplasm Metastasis | 1 | 2013 | 4909 | 0.050 |
Why?
|
Platelet Count | 1 | 2024 | 782 | 0.050 |
Why?
|
Kidney | 1 | 2017 | 7033 | 0.050 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2014 | 4372 | 0.050 |
Why?
|
Mice, SCID | 2 | 2019 | 2621 | 0.050 |
Why?
|
Life Cycle Stages | 1 | 2022 | 160 | 0.050 |
Why?
|
POU Domain Factors | 1 | 2021 | 47 | 0.050 |
Why?
|
Child, Preschool | 5 | 2016 | 42224 | 0.050 |
Why?
|
Apolipoproteins A | 1 | 2021 | 95 | 0.050 |
Why?
|
MyoD Protein | 1 | 2021 | 141 | 0.050 |
Why?
|
beta-Globins | 1 | 2021 | 111 | 0.050 |
Why?
|
Lamivudine | 1 | 2022 | 366 | 0.040 |
Why?
|
Electroporation | 1 | 2021 | 233 | 0.040 |
Why?
|
Mice, Inbred C57BL | 4 | 2024 | 22127 | 0.040 |
Why?
|
Myeloid Cells | 2 | 2019 | 822 | 0.040 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2010 | 2897 | 0.040 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2021 | 307 | 0.040 |
Why?
|
Petromyzon | 1 | 2019 | 7 | 0.040 |
Why?
|
Targeted Gene Repair | 1 | 2019 | 20 | 0.040 |
Why?
|
Apolipoprotein C-III | 1 | 2021 | 210 | 0.040 |
Why?
|
Chemokines | 1 | 2024 | 956 | 0.040 |
Why?
|
Bacteriophage lambda | 1 | 2019 | 142 | 0.040 |
Why?
|
Multifactor Dimensionality Reduction | 1 | 2019 | 10 | 0.040 |
Why?
|
Deamination | 1 | 2019 | 25 | 0.040 |
Why?
|
HCT116 Cells | 1 | 2020 | 405 | 0.040 |
Why?
|
Acidaminococcus | 1 | 2019 | 9 | 0.040 |
Why?
|
Doxycycline | 1 | 2021 | 344 | 0.040 |
Why?
|
Fibroblasts | 1 | 2009 | 4137 | 0.040 |
Why?
|
Combinatorial Chemistry Techniques | 1 | 2019 | 135 | 0.040 |
Why?
|
Middle Aged | 12 | 2024 | 220853 | 0.040 |
Why?
|
Transposases | 1 | 2019 | 104 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 3 | 2018 | 17897 | 0.040 |
Why?
|
Genetic Markers | 2 | 2016 | 2599 | 0.040 |
Why?
|
Erythroid Precursor Cells | 1 | 2019 | 212 | 0.040 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2020 | 696 | 0.040 |
Why?
|
Steroids | 1 | 2023 | 929 | 0.040 |
Why?
|
Interferons | 1 | 2022 | 702 | 0.040 |
Why?
|
Neurons | 2 | 2019 | 9428 | 0.040 |
Why?
|
Cell Survival | 2 | 2019 | 5778 | 0.040 |
Why?
|
Hep G2 Cells | 1 | 2019 | 374 | 0.040 |
Why?
|
Prognosis | 3 | 2024 | 29687 | 0.040 |
Why?
|
Myoblasts | 1 | 2019 | 231 | 0.040 |
Why?
|
Immunity, Cellular | 1 | 2023 | 1553 | 0.040 |
Why?
|
Myeloid Progenitor Cells | 1 | 2018 | 112 | 0.040 |
Why?
|
Interferon Regulatory Factors | 1 | 2019 | 261 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2016 | 9278 | 0.040 |
Why?
|
Valine | 1 | 2019 | 408 | 0.040 |
Why?
|
Th17 Cells | 1 | 2024 | 794 | 0.040 |
Why?
|
INDEL Mutation | 1 | 2018 | 265 | 0.040 |
Why?
|
Molecular Dynamics Simulation | 1 | 2020 | 427 | 0.040 |
Why?
|
Erythroid Cells | 1 | 2019 | 237 | 0.040 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2016 | 5321 | 0.040 |
Why?
|
Cell Communication | 1 | 2024 | 1651 | 0.040 |
Why?
|
Metabolic Networks and Pathways | 1 | 2021 | 790 | 0.040 |
Why?
|
Biological Clocks | 1 | 2019 | 318 | 0.030 |
Why?
|
Hippocampus | 2 | 2024 | 3754 | 0.030 |
Why?
|
Base Pair Mismatch | 1 | 2016 | 92 | 0.030 |
Why?
|
Plasmids | 1 | 2021 | 2261 | 0.030 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2019 | 504 | 0.030 |
Why?
|
Glutamine | 1 | 2019 | 574 | 0.030 |
Why?
|
Cluster Analysis | 2 | 2014 | 2706 | 0.030 |
Why?
|
Aged, 80 and over | 6 | 2020 | 58952 | 0.030 |
Why?
|
Glycine | 1 | 2019 | 659 | 0.030 |
Why?
|
Flow Cytometry | 2 | 2019 | 5871 | 0.030 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2021 | 725 | 0.030 |
Why?
|
Gene Library | 1 | 2018 | 1054 | 0.030 |
Why?
|
Pregnancy | 1 | 2017 | 29893 | 0.030 |
Why?
|
Streptococcus thermophilus | 1 | 2015 | 22 | 0.030 |
Why?
|
RNA Interference | 2 | 2016 | 2816 | 0.030 |
Why?
|
Transcriptional Activation | 1 | 2021 | 1749 | 0.030 |
Why?
|
Coculture Techniques | 1 | 2019 | 1334 | 0.030 |
Why?
|
Peptide Initiation Factors | 1 | 2015 | 53 | 0.030 |
Why?
|
Transgenes | 1 | 2018 | 1008 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2018 | 942 | 0.030 |
Why?
|
STAT3 Transcription Factor | 1 | 2019 | 872 | 0.030 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2019 | 1168 | 0.030 |
Why?
|
Liver | 1 | 2010 | 7514 | 0.030 |
Why?
|
Apoptosis | 1 | 2010 | 9477 | 0.030 |
Why?
|
Muscles | 1 | 2019 | 1568 | 0.030 |
Why?
|
Hydrazones | 1 | 2015 | 103 | 0.030 |
Why?
|
Adenine | 1 | 2020 | 986 | 0.030 |
Why?
|
Peptide Chain Initiation, Translational | 1 | 2015 | 99 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2020 | 2509 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2019 | 1240 | 0.030 |
Why?
|
Mutagenesis | 1 | 2018 | 1226 | 0.030 |
Why?
|
Directed Molecular Evolution | 1 | 2015 | 159 | 0.030 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2019 | 736 | 0.030 |
Why?
|
Transcription, Genetic | 2 | 2019 | 7571 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2020 | 18926 | 0.030 |
Why?
|
Sequence Alignment | 1 | 2018 | 2175 | 0.030 |
Why?
|
Cloning, Molecular | 1 | 2019 | 4167 | 0.030 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2014 | 286 | 0.030 |
Why?
|
Caliciviridae Infections | 1 | 2013 | 29 | 0.030 |
Why?
|
Models, Genetic | 2 | 2014 | 3430 | 0.030 |
Why?
|
Stromal Cells | 1 | 2019 | 1329 | 0.030 |
Why?
|
RNA, Small Untranslated | 1 | 2014 | 77 | 0.030 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2014 | 704 | 0.030 |
Why?
|
Cochlea | 1 | 2019 | 846 | 0.030 |
Why?
|
RNA, Messenger | 2 | 2021 | 12747 | 0.030 |
Why?
|
Acute Disease | 1 | 2023 | 7226 | 0.030 |
Why?
|
Cell Division | 1 | 2020 | 4451 | 0.030 |
Why?
|
Neoplasm Staging | 2 | 2019 | 11119 | 0.030 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2021 | 3592 | 0.030 |
Why?
|
T-Lymphocytes | 2 | 2021 | 10203 | 0.030 |
Why?
|
Bees | 1 | 2012 | 46 | 0.030 |
Why?
|
Body Mass Index | 1 | 2010 | 12952 | 0.030 |
Why?
|
Rotavirus Infections | 1 | 2013 | 84 | 0.030 |
Why?
|
Intestinal Mucosa | 1 | 2023 | 3031 | 0.030 |
Why?
|
Animals, Genetically Modified | 1 | 2017 | 1558 | 0.030 |
Why?
|
Ribosomal Proteins | 1 | 2015 | 370 | 0.030 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2016 | 682 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2019 | 1838 | 0.030 |
Why?
|
Methylation | 1 | 2015 | 1070 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2021 | 2414 | 0.020 |
Why?
|
Signal Transduction | 3 | 2024 | 23416 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2022 | 2915 | 0.020 |
Why?
|
Protein Conformation | 1 | 2019 | 3933 | 0.020 |
Why?
|
Transfection | 1 | 2019 | 5748 | 0.020 |
Why?
|
Insect Proteins | 1 | 2012 | 254 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2021 | 2871 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2022 | 2827 | 0.020 |
Why?
|
Genes, Regulator | 1 | 2012 | 373 | 0.020 |
Why?
|
Oligonucleotide Probes | 1 | 2011 | 416 | 0.020 |
Why?
|
Plasmodium berghei | 1 | 2012 | 159 | 0.020 |
Why?
|
Vocabulary, Controlled | 1 | 2012 | 167 | 0.020 |
Why?
|
Aminopyridines | 1 | 2015 | 573 | 0.020 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2017 | 1132 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2014 | 2010 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2015 | 1737 | 0.020 |
Why?
|
Thrombosis | 1 | 2024 | 2944 | 0.020 |
Why?
|
Nuclear Transfer Techniques | 1 | 2010 | 61 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2013 | 991 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2016 | 3577 | 0.020 |
Why?
|
Chemical Fractionation | 1 | 2010 | 61 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2020 | 2803 | 0.020 |
Why?
|
Genes, Neoplasm | 1 | 2012 | 370 | 0.020 |
Why?
|
Markov Chains | 1 | 2013 | 965 | 0.020 |
Why?
|
Exons | 1 | 2016 | 2380 | 0.020 |
Why?
|
Mice, Inbred CBA | 1 | 2010 | 438 | 0.020 |
Why?
|
Genes, myc | 1 | 2011 | 390 | 0.020 |
Why?
|
DNA Topoisomerases, Type II | 1 | 2010 | 121 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2022 | 3048 | 0.020 |
Why?
|
Anopheles | 1 | 2012 | 192 | 0.020 |
Why?
|
Nucleic Acid Hybridization | 1 | 2011 | 1301 | 0.020 |
Why?
|
Rats | 2 | 2019 | 23704 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2021 | 13402 | 0.020 |
Why?
|
Escherichia coli Infections | 1 | 2013 | 518 | 0.020 |
Why?
|
Vaccines, Synthetic | 1 | 2012 | 612 | 0.020 |
Why?
|
Cell Movement | 1 | 2021 | 5195 | 0.020 |
Why?
|
Membrane Proteins | 2 | 2019 | 7851 | 0.020 |
Why?
|
Cytokines | 1 | 2024 | 7386 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2013 | 1602 | 0.020 |
Why?
|
Protein Multimerization | 1 | 2014 | 974 | 0.020 |
Why?
|
Sex Factors | 2 | 2013 | 10553 | 0.020 |
Why?
|
Drug Resistance | 1 | 2015 | 1594 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2011 | 748 | 0.020 |
Why?
|
Immunotherapy | 1 | 2024 | 4642 | 0.020 |
Why?
|
Magnetics | 1 | 2011 | 598 | 0.020 |
Why?
|
Smoking | 2 | 2016 | 9055 | 0.020 |
Why?
|
Phenotype | 2 | 2019 | 16575 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2019 | 3596 | 0.020 |
Why?
|
Microscopy, Electron | 1 | 2011 | 2561 | 0.020 |
Why?
|
Adult | 6 | 2024 | 221119 | 0.020 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2010 | 330 | 0.020 |
Why?
|
Staphylococcus aureus | 1 | 2015 | 1450 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2019 | 9520 | 0.020 |
Why?
|
Uncertainty | 1 | 2012 | 752 | 0.020 |
Why?
|
Risk Factors | 3 | 2024 | 74239 | 0.020 |
Why?
|
Survival Analysis | 1 | 2019 | 10088 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2021 | 5782 | 0.020 |
Why?
|
Hypothalamus | 1 | 2011 | 999 | 0.020 |
Why?
|
Quality-Adjusted Life Years | 1 | 2012 | 1723 | 0.020 |
Why?
|
Age Factors | 2 | 2013 | 18384 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2015 | 2058 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15308 | 0.020 |
Why?
|
Serine Endopeptidases | 1 | 2010 | 1022 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2013 | 22174 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2016 | 2813 | 0.010 |
Why?
|
Child | 3 | 2023 | 80152 | 0.010 |
Why?
|
Macrophages | 1 | 2019 | 5753 | 0.010 |
Why?
|
Adolescent | 4 | 2013 | 88298 | 0.010 |
Why?
|
Receptors, Androgen | 1 | 2010 | 1077 | 0.010 |
Why?
|
Cohort Studies | 2 | 2020 | 41496 | 0.010 |
Why?
|
Linear Models | 1 | 2014 | 5869 | 0.010 |
Why?
|
Genotype | 1 | 2018 | 12985 | 0.010 |
Why?
|
Pluripotent Stem Cells | 1 | 2010 | 794 | 0.010 |
Why?
|
Chronic Disease | 1 | 2018 | 9319 | 0.010 |
Why?
|
Metabolome | 1 | 2010 | 989 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2019 | 10422 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2010 | 20982 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2012 | 6199 | 0.010 |
Why?
|
Androgens | 1 | 2010 | 1283 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2021 | 7407 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2012 | 2731 | 0.010 |
Why?
|
Regression Analysis | 1 | 2012 | 6345 | 0.010 |
Why?
|
Malaria | 1 | 2012 | 1225 | 0.010 |
Why?
|
Mortality | 1 | 2012 | 2896 | 0.010 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2010 | 2820 | 0.010 |
Why?
|
Repressor Proteins | 1 | 2012 | 2974 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2011 | 8164 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2015 | 5662 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2024 | 80674 | 0.010 |
Why?
|
Young Adult | 2 | 2012 | 59221 | 0.010 |
Why?
|
Disease Progression | 1 | 2010 | 13511 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 2011 | 6341 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2019 | 64681 | 0.010 |
Why?
|
Risk Assessment | 1 | 2012 | 24021 | 0.010 |
Why?
|
Time Factors | 1 | 2010 | 39957 | 0.000 |
Why?
|
Antineoplastic Agents | 1 | 2010 | 13632 | 0.000 |
Why?
|